Literature DB >> 32921737

International Efforts to Save Healthcare Personnel during COVID-19.

Kawthar Mohamed1, Nima Rezaei2, Eduardo Rodríguez-Román3, Farzaneh Rahmani4, Hongbo Zhang5, Mariya Ivanovska6, Sara A Makka7, Musa Joya8, Rangarirai Makuku9, Rayan Goda10, Samaneh Zoghi11, Sevan Irtsyan12, Irene Ling13, Faten Attig-Bahar14, Esra Hazar Sayar15, Chagajeg Soloukey16.   

Abstract

Coronavirus disease 2019 (COVID-19) pandemic is a global challenge. Several governments of the world have decided to take drastic actions in order to combat the spread of the disease, including the closing of air, maritime and land borders, as an extreme measure of isolation of each country/region. However, such measures had not prevented the disease from spreading globally; as COVID-19 has already spread in almost all countries. This virus's main victims are the healthcare personnel (HCP), who are physically and psychologically affected. The HCP serves as the first line of defense against this pandemic, what if we faced a significant loss in their number? And what if our HCP was going through a deep dark depression? The condition would be terrifying not only for now but also in the future. This raises the need for an intensified International collaboration, that mainly supports the HCP. We are throwing by challenging moments, and it is clear that social distancing, cooperation, hygiene awareness and abide by the recommendation and help of all governments, as well as obtaining the support of international organizations could be an excellent tool for preventing an increase in the number of cases, principally in countries and regions were COVID-19 is in the early stage of the epidemic. However, this is not the final solution for the current pandemic. An intensified global program, which mainly supports the HCP, then considers the other aspects of the COVID19 pandemic might bring this pandemic to a peaceful end.

Entities:  

Mesh:

Year:  2020        PMID: 32921737      PMCID: PMC7716974          DOI: 10.23750/abm.v91i3.9891

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


An emerging virus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the etiological agent of the coronavirus disease 2019 (COVID-19). The first cases of COVID-19 were reported on December 31st, 2019; all 41 reported individuals resided in Wuhan, Hubei province, China (1). However, symptoms of these positive patients appeared at least as early as December 1st, 2019 (2). Thus, the outbreak of COVID-19 has been suggested to have begun two months prior (3). This disease, that was contained to one specific region, in one specific province, in one specific country, is currently plaguing the entirety of the world (4). Indeed, the World Health Organization (WHO) declared a pandemic on March 11th, 2020. At that point, 118,000 cases in 114 countries were known, and 4,291 people had already lost their lives (5). Meanwhile it was difficult to guess that more than 1,500,000 new cases in almost all countries and territories will be identified within a month (April 11th, 2020) after announcing the pandemic; and more than 5.7 million affected cases and more than 350,000 deaths in less than 6 months from the first reported case (May 27th, 2020) (6). Despite the fact that an epidemiologic study is needed to validate these numbers, the current estimates are alarming enough for the members of the scientific community, government officials, and even many lay citizens, to realize the severity of this pandemic (7, 8). So, this generates an alarm all over the world, since it puts the lives of many people at risk, especially those with advanced age and/or with associated diseases such as diabetes mellitus, hypertension and cardiovascular problems, which increase the morbidity and mortality of patients with COVID-19 (2). So, social (physical) distancing has been practiced in several countries. Such measures are installed for periods ranging from 2 weeks to 2 months, as a maximum measure to prevent the virus from spreading among countries, states and citizens. We can witness the success of this rigorous method in China, where social distancing was applied in regions other than Hubei, thus having a lower number of confirmed cases, considering the official report. Conversely, the opposite is true in countries such as the USA, Spain, and Italy, where there was a delay in applying social distancing, resulting to the highest confirmed cases in these countries (9) . It worth mentioning that healthcare personnel (HCP) are the group, who are not only suffered from family distancing (even parents and/or children), but also have been at a higher risk of infection with COVID-19 since the start of the pandemic (10). A study from China showed 2055 confirmed cases of COVID-19 among HCP during a 2-month period (December 18th, 2019 to February 20th, 2020) (11). In another report from Italy, the rate of infection in HCP was reported around 20% (12).Having little information about the new virus caused an increase in the HCP infection rates. Medical HCP in different fields have to act in a short time interval; some of them had not enough experience, knowledge and information about using personal protective equipment (12), especially at the beginning of before pandemic. Moreover, some HCP, who were the first line of defense against the COVID-19 pandemic, had to work long hours without any break due to the large number of patients. The rapid expansion of the epidemic also caused a severe shortage of critical PPE. Such excessive amounts of workload pressure and psychological distress has led to caregiver burnout in HCP (10, 13, 14) So, international efforts are needed to do something quickly. Apart from ‘lockdown’ measures for public, which reduces extra pressure of affected individuals to the health system, another useful strategy is rapid testing. As it was modeled with Ebola, to control a pandemic in one year period, there is a need to test 80% of the symptomatic cases within one day of their symptoms appearance (15). Currently, the most used test for the diagnosis of COVID-19 is reverse transcription polymerase chain reaction (rRT-PCR); the test that tries to find the viral genetic material in the patient’s specimen. Unfortunately, despite the test’s quality, several practical drawbacks, such as the high cost and level of expertise, prevent its worldwide use for all. In China, an insufficiency of the test kits prompted the replacement of rRT-PCR with the computed tomography (CT) scan, followed by confirmatory laboratory tests. Not only does such a test face more limitations in terms of accuracy, CT scans, too, are still a luxury in some healthcare systems; thus, the urgency of having a rapid, affordable and cost effective test was arose (16). Despite many efforts which are being made to create cost-efficient alternatives, it is still questionable whether these tests can be made available on a global scale, and what will be the economic burden of these alternatives. Indeed, according to the United Nations trade agency the economic burden of this global pandemic is already estimated to be more than US $1 trillion. In global crises such as these, funding is not the only commodity that is scarce. Time and timing, too, seem to be exceptionally valuable in preventing the spread of the disease. We should learn from our previous mistakes, if we want to prevent history from repeating itself. One example that we can recall within this context is the Ebola epidemic. A magnificent testing kit was made in October 2014, but its obvious effects were shown no earlier than June 2015. This was ’too late’, as the pandemic peak had dropped by then. This crucial loss of time occurred due to a lack of a rapid approval system; authorized by the FDA for example and a robust financial support for the manufacturers (15). The total number of reported confirmed cases with COVID-19 and deaths in general population and Healthcare personnel (Date: May: 22, 2020) Indications: The – means no data available For * the numbers were retrieved from domestic news. The total number of deaths worldwide in health care personnel due to COVID-19 (Date: May 22, 2020) Sadly enough, this story is not just one of time and money. COVID-19 is not only physically debilitating those who are infected, as the disease is revealing its immense psychological impact on all members of our global society, whether that is those who are infected, the health promoters and medics that care for such patients, or those of us who are still healthy, but quarantined. Indeed, those health care workers at the frontline, who are engaged in direct diagnosis, treatment, and care of patients with COVID-19, are said to have a higher risk of symptoms of depression, which can be debilitating as well as apathetic on long-term exhaustion (17). What’s more, many members of the general public (aka covidiots), who were (and perhaps still are) less informed, started panic-buying and ignoring social distancing rules. Attention must be sought and more efforts must be placed by psychological and mental health experts on three main levels: (1) healthcare workers and medical doctors, who are at risk of burden and burnout, even if trained to adapt to emergencies; (2) the public nation in quarantine, who might receive a suggested at-home creative plan; and (3) post-disease outbreak support for the recovered and medical teams. If these psychological factors are not handled with an equal amount of care as the physico-biological and economic problems, the impact of the disease will not just be seen, but also felt for many years following the pandemic. This was only a chapter of this horrible scenario. Everything becomes worse, if we consider that despite the efforts that are done, no clear guidance is there for the diagnosis as well as a specific treatment; unfortunately supportive care is the only choice (18). It might be quite optimistic that six vaccine developing programs from the USA, China, South Korea, Germany and the UK have started the Phase I vaccine candidates, but this is not the early solution that everyone expects, because it has been said that we at least need 12-18 months to bring these vaccines to the markets, and this time is estimated based on ideal conditions (19). In conclusion, it is clear that social distancing, cooperation, hygiene awareness (common sense) and abide by the recommendation and help of all governments are the best available solutions. However, these are not decisive solutions for the HCP dilemma during the current pandemic. An intensified global program is needed to control this pandemic at the lowest possible costs and the highest possible quality. International efforts to provide PPE for all HCP around the world as well a program to support their mental health are an urgent need, which should not be neglected.
Table 1.

The total number of reported confirmed cases with COVID-19 and deaths in general population and Healthcare personnel (Date: May: 22, 2020)

Reporting Country/ Territory/AreaTotal confirmed case (20)Total deaths (20)Healthcare personnel deaths (21)Healthcare personnel/total deaths
Africa
Algeria7,72857561.04%
South Africa19,13736951.3%
Nigeria7,01621131.42%
Cameroon4,28815621.28%
Ghana6,2693113.225%
Central African Republic43600
Rwanda32000
Uganda26400
Mozambique16200
Burundi4200
Eritrea3900
Namibia1800-
Seychelles1100
Lesotho100
Guinea3,06719--
Senegal2,81533--
Côte d’Ivoire2,30129--
Democratic Republic of the Congo1 94462--
Gabon1,56712--
Guinea-Bissau1,1096--
Kenya1,10950--
Equatorial Guinea96011--
Mali93155--
Niger92460--
Zambia8667--
Burkina Faso81252--
Chad58858--
Sierra Leone58535--
United Republic of Tanzania50921--
South Sudan4736--
Congo46916--
Madagascar4052--
Ethiopia3995--
Cabo Verde3563--
Togo35412--
Mauritius33210--
Liberia24023--
Eswatini2202--
Mauritania1735--
São Tomé and Príncipe1658--
Benin1353--
Malawi723--
Angola603--
Zimbabwe513--
Comoros341--
Botswana291--
Gambia241-
Total Reported HCP Deaths17
Americas
Mexico56 ,5946, 0902013.3%
United States of America1, 525 ,18691, 527190 (2 suicides)0.2%
Brazil291, 57918, 859810.42%
Ecuador34, 8542, 888812.8%
Peru104, 0203, 024240.79%
Canada80, 5556, 062150.24%
Argentina9,28340371.7%
Colombia17, 68763060.95%
Panama9,97728741.39%
Bolivia4,91919942%
Costa Rica88210220%
Venezuela82410220%
Chile53, 61754410.18%
Dominican Republic13, 65744810.22%
Honduras3,10015110.66%
Paraguay8361119%
Uruguay7462015%
Guyana12510110%
Bahamas971119%
Grenada2200
Saint Lucia1800
Saint Vincent and the Grenadines1800
Dominica1600
Guatemala2,26545--
Cuba1,90880--
El Salvador1, 64032--
Haiti66322--
Jamaica5299--
Nicaragua27917--
Trinidad and Tobago1168--
Barbados907-
Antigua and Barbuda253-
Belize182-
Total Reported HCP Deaths624
Eastern Mediterranean
*Iran (Islamic Republic of)129,3417,2491071.48%
*Iraq3,8771402517.85%
Pakistan50, 6941, 06790.84%
Egypt15, 00369671%
Afghanistan9,21620531.46%
Morocco7,21119631.5%
United Arab Emirates26, 89823720.84%
Kuwait18, 60912921.55%
Oman6 ,3703213.1%
*Bahrain8,1741200
Saudi Arabia65, 077351--
Qatar38, 65117--
Sudan3,138121--
Djibouti2,04710--
Somalia1,59461--
Tunisia1,04647--
Lebanon1,02426--
Jordan6849--
Yemen19733--
Libya713--
Syrian Arab Republic583--
Total Reported HCP Deaths159
Europe
The United Kingdom250, 91236,0421490.41%
Italy228,00632, 486131(one suicide)0.4%
Spain233, 03727,940400.14%
Turkey153,5484,249350.82%
France141,59028,164230.08%
Russian Federation326,4483,249200.6%
*Germany177,2128,17480.097%
Serbia10,91923783.37%
Republic of Moldova6,70423341.7%
Belgium56,2359,18630.03%
Belarus34,30319031.58%
Ukraine20,14858820.34%
Poland20,14397220.2%
Romania17,5851,15120.17%
*Bulgaria2,3721252
Bosnia and Herzegovina2,35213921.4%
Sweden32,1723,87110.03%
Ireland24,3911,58310.06%
Austria16,33263310.16%
Finland6,49330610.32%
Hungary3,67847610.2%
Greece2,85316810.6%
Netherlands44,7005,775--
Switzerland30, 6111,637--
Portugal29,9121,277--
Denmark11,182561--
Czech Republic8,754306--
Norway8,268234--
Kazakhstan7,59735--
Armenia5,92874--
Luxembourg3,980109--
Azerbaijan3,74944--
Uzbekistan3,00613
Tajikistan2,35044--
Croatia2,23797--
North Macedonia1,898111--
Iceland1,80310--
Estonia1,80064--
Lithuania1,59461--
Slovakia1,50228--
Slovenia1,468106--
Kyrgyzstan1,35014--
Latvia1,02522--
Albania96931--
Cyprus92317--
Andorra76251--
Georgia72312--
San Marino67241--
Total Reported HCP Deaths440
South-East Asia
Indonesia20,1621,278272.1%
India118,4473,58390.25%
Thailand3,0375623.5%
Bangladesh28 51140810.24%
Timor-Leste24000
Maldives1,2164--
Sri Lanka1,0559--
Nepal4873--
Myanmar1996--
Total Reported HCP Deaths39
Western Pacific region
China84,5204,645300.65%
Philippines13,434846303.5%
Malaysia7,05911421.8%
Republic of Korea11,14226410.38%
Australia7,08110011%
Viet Nam324000
Brunei Darussalam141100
Mongolia140000
Cambodia123000
Lao People’s Democratic Republic19000
Fiji18000
Papua New Guinea8000
Singapore29,81223--
Japan16,513796--
New Zealand1,15421--
Total Reported HCP Deaths64
Total worldwide Reported HCP Deaths1343

Indications:

The – means no data available

For * the numbers were retrieved from domestic news.

  11 in total

1.  All together to Fight COVID-19.

Authors:  Sara Momtazmanesh; Hans D Ochs; Lucina Q Uddin; Matjaz Perc; John M Routes; Duarte Nuno Vieira; Waleed Al-Herz; Safa Baris; Carolina Prando; Laszlo Rosivall; Amir Hamzah Abdul Latiff; Timo Ulrichs; Vasili Roudenok; Juan Carlos Aldave Becerra; Deepak B Salunke; Ekaterini Goudouris; Antonio Condino-Neto; Anzhela Stashchak; Oleksandr Kryvenko; Mykola Stashchak; Anastasia Bondarenko; Nima Rezaei
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

2.  Ebola control: rapid diagnostic testing.

Authors:  Ranu S Dhillon; Devabhaktuni Srikrishna; Robert F Garry; Gerardo Chowell
Journal:  Lancet Infect Dis       Date:  2014-11-19       Impact factor: 25.071

3.  New coronavirus threat galvanizes scientists.

Authors:  Jon Cohen
Journal:  Science       Date:  2020-01-31       Impact factor: 47.728

4.  COVID-19: Developing from an Outbreak to A Pandemic.

Authors:  Sara Hanaei; Nima Rezaei
Journal:  Arch Med Res       Date:  2020-05-13       Impact factor: 2.235

5.  COVID-19 and the cardiovascular system.

Authors:  Ying-Ying Zheng; Yi-Tong Ma; Jin-Ying Zhang; Xiang Xie
Journal:  Nat Rev Cardiol       Date:  2020-05       Impact factor: 32.419

6.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  COVID-19 and telemedicine: Immediate action required for maintaining healthcare providers well-being.

Authors:  Bobak Moazzami; Niloofar Razavi-Khorasani; Arash Dooghaie Moghadam; Ermia Farokhi; Nima Rezaei
Journal:  J Clin Virol       Date:  2020-04-04       Impact factor: 3.168

8.  Borderless collaboration is needed for COVID-19-A disease that knows no borders.

Authors:  Kawthar Mohamed; Eduardo Rodríguez-Román; Farzaneh Rahmani; Hongbo Zhang; Mariya Ivanovska; Sara A Makka; Musa Joya; Rangarirai Makuku; Md Shahidul Islam; Nesrine Radwan; Laila Rahmah; Rayan Goda; Sunny O Abarikwu; Mujtaba Shaw; Samaneh Zoghi; Sevan Irtsyan; Irene Ling; Orsolya Cseprekal; Attig-Bahar Faten; Esra Hazar Sayar; Chagajeg Soloukey; Giulia Grancini; Nima Rezaei
Journal:  Infect Control Hosp Epidemiol       Date:  2020-04-22       Impact factor: 3.254

Review 9.  COVID-19 and Italy: what next?

Authors:  Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Lancet       Date:  2020-03-13       Impact factor: 79.321

10.  Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.

Authors:  Jianbo Lai; Simeng Ma; Ying Wang; Zhongxiang Cai; Jianbo Hu; Ning Wei; Jiang Wu; Hui Du; Tingting Chen; Ruiting Li; Huawei Tan; Lijun Kang; Lihua Yao; Manli Huang; Huafen Wang; Gaohua Wang; Zhongchun Liu; Shaohua Hu
Journal:  JAMA Netw Open       Date:  2020-03-02
View more
  9 in total

Review 1.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

2.  Clinical Characteristics and Potential Risk Factors Associated with the SARS-CoV-2 Infection: Survey on a Health Care Workers (HCWs) Population in Northern Italy.

Authors:  Viola Novelli; Federico Fassio; Guido Resani; Martino Bussa; Alessandro Durbano; Alessandro Meloni; Giovanni Oliva; Sara Cutti; Daniela Girardi; Anna Odone; Simona Villani; Carlo Marena; Alba Muzzi; Maria Cristina Monti
Journal:  Int J Environ Res Public Health       Date:  2022-07-04       Impact factor: 4.614

Review 3.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

Review 4.  Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.

Authors:  Kawthar Mohamed; Niloufar Yazdanpanah; Amene Saghazadeh; Nima Rezaei
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

Review 5.  A systematic review of pregnant women with COVID-19 and their neonates.

Authors:  Mona Mirbeyk; Amene Saghazadeh; Nima Rezaei
Journal:  Arch Gynecol Obstet       Date:  2021-04-02       Impact factor: 2.493

Review 6.  Computed tomography scan in COVID-19: a systematic review and meta-analysis.

Authors:  Pouya Mahdavi Sharif; Mehran Nematizadeh; Mahdia Saghazadeh; Amene Saghazadeh; Nima Rezaei
Journal:  Pol J Radiol       Date:  2022-01-05

Review 7.  COVID-19 vaccinations: The unknowns, challenges, and hopes.

Authors:  Kawthar Mohamed; Piotr Rzymski; Md Shahidul Islam; Rangarirai Makuku; Ayesha Mushtaq; Amjad Khan; Mariya Ivanovska; Sara A Makka; Fareeda Hashem; Leander Marquez; Orsolya Cseprekal; Igor Salerno Filgueiras; Dennyson Leandro M Fonseca; Essouma Mickael; Irene Ling; Amanuel Godana Arero; Sarah Cuschieri; Kseniia Minakova; Eduardo Rodríguez-Román; Sunny O Abarikwu; Attig-Bahar Faten; Giulia Grancini; Otavio Cabral-Marques; Nima Rezaei
Journal:  J Med Virol       Date:  2021-12-10       Impact factor: 20.693

8.  SARS-CoV-2 Omicron (B.1.1.529) Variant: No Time to Wait!

Authors:  Shayan Rahmani; Nima Rezaei
Journal:  Acta Biomed       Date:  2022-05-11

Review 9.  Health workforce retention in low-income settings: an application of the Root Stem Model.

Authors:  Rangarirai Makuku; Ali Mohammad Mosadeghrad
Journal:  J Public Health Policy       Date:  2022-08-17       Impact factor: 3.526

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.